ONWRYOnward Med NV

About Onward Med NV (ONWRY)

Onward Med NV (ONWRY) is a N/A company headquartered in Eindhoven, Netherlands whose shares trade over-the-counter on the OTCQX tier.

ONWARD Medical is a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries (SCI). ONWARD Medical's work builds on more than a decade of basic science, pre-clinical, and clinical research conducted at the world's leading neuroscience laboratories.

Products and services

ONWARD has three purpose-built neuromodulation platforms that stimulate the spinal cord to restore movement and other critical functions lost after spinal cord injury (SCI) and other movement disabilities: o ARC-EX System, an external platform that stimulates through the skin o ARC-IM System, an investigational implanted neuromodulation platform o ARC-BCI, an investigational implanted platform that combines the ARC-IM System with an implanted brain-computer interface (BCI) to restore thought-driven movement via our wireless DigitalBridge

ONWRY key facts

Ticker symbol

ONWRY

Market tier

OTCQX

Headquarters

Eindhoven, Netherlands

Country of incorporation

NL

Year of incorporation

2015

Employees

106

Estimated market cap

$201.28M (as of May 8, 2025)

Shares outstanding

44,628,834

Reporting standard

International Reporting: Euronext Brussels

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Onward Med NV leadership

• David Lawrence Marver — CEO
• Amori Fraser — Finance Director
• Lorenzo Fanti — Other
• Alexandre Casteau — Corporate Development Officer

Explore more: OTCQX stocks · OTC stocks starting with O